83 related articles for article (PubMed ID: 3520730)
1. Effect of several amino acid phosphonates and other compounds on rat brain and kidney peptidases.
Weiss B; Hui KS; Benuck M; Hui M; Berg MJ; Lajtha A
Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):81-92. PubMed ID: 3520730
[TBL] [Abstract][Full Text] [Related]
2. Effect of several amino acid phosphonates and related compounds on rat brain aminopeptidases.
Weiss B; Hui KS; Hui M; Lajtha A
Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):351-8. PubMed ID: 3671885
[TBL] [Abstract][Full Text] [Related]
3. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.
Chérot P; Devin J; Fournié-Zaluski MC; Roques BP
Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
Altstein M; Blumberg S; Vogel Z
Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure activity relationships of novel non-peptidic metallo-aminopeptidase inhibitors.
Albrecht S; Defoin A; Salomon E; Tarnus C; Wetterholm A; Haeggström JZ
Bioorg Med Chem; 2006 Nov; 14(21):7241-57. PubMed ID: 16844380
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
Hazato T; Kase R; Ueda H; Takagi H; Katayama T
Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
[TBL] [Abstract][Full Text] [Related]
7. Microvillar membrane neutral endopeptidases.
Kenny AJ; Fulcher IS; Ridgwell K; Ingram J
Acta Biol Med Ger; 1981; 40(10-11):1465-71. PubMed ID: 6123211
[TBL] [Abstract][Full Text] [Related]
8. [Partial characteristics of the basic phenylmethylsulfonylfluoride-inhibited carboxypeptidase from cat brain].
Vernigora AN; Nikishin NN; Gengin MT
Biokhimiia; 1995 Nov; 60(11):1860-6. PubMed ID: 8590758
[TBL] [Abstract][Full Text] [Related]
9. Novel 3-amino-2-hydroxy acids containing protease inhibitors. Part 1: Synthesis and kinetic characterization as aminopeptidase P inhibitors.
Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
Bioorg Med Chem; 2005 Aug; 13(16):4806-20. PubMed ID: 15993089
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of inhibitors incorporating beta -amino acids of metalloendopeptidase EC 3.4.24.15.
Steer DL; Lew RA; Perlmutter P; Smith AI; Aguilar MI
J Pept Sci; 2000 Sep; 6(9):470-7. PubMed ID: 11016884
[TBL] [Abstract][Full Text] [Related]
11. Degradation of bradykinin in human urine by carboxypeptidase Y-like exopeptidase and neutral endopeptidase and their inhibition by ebelactone B and phosphoramidon.
Saito M; Majima M; Katori M; Sanjou Y; Suyama I; Shiokawa H; Koshiba K; Aoyagi T
Int J Tissue React; 1995; 17(5-6):181-90. PubMed ID: 8835628
[TBL] [Abstract][Full Text] [Related]
12. [Neuropeptidases responsible for the inactivation of enkephalins and the pharmacology of their inhibitors].
Schwartz JC; de la Baume S; Bouthenet ML; Giros B; Gros C; Llorens-Cortes C; Pollard H; Sales N; Solhonne B; Costentin J
J Pharmacol; 1986; 17 Suppl 2():104-22. PubMed ID: 3546953
[No Abstract] [Full Text] [Related]
13. alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.
Biasone A; Tortorella P; Campestre C; Agamennone M; Preziuso S; Chiappini M; Nuti E; Carelli P; Rossello A; Mazza F; Gallina C
Bioorg Med Chem; 2007 Jan; 15(2):791-9. PubMed ID: 17088065
[TBL] [Abstract][Full Text] [Related]
14. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of a rat brain enkephalin aminopeptidase.
Wagner GW; Dixon JE
J Neurochem; 1981 Sep; 37(3):709-13. PubMed ID: 7276951
[TBL] [Abstract][Full Text] [Related]
16. Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord.
Nishimura K; Hazato T
Biochem Biophys Res Commun; 1993 Jul; 194(2):713-9. PubMed ID: 8343155
[TBL] [Abstract][Full Text] [Related]
17. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
[TBL] [Abstract][Full Text] [Related]
18. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
19. Peptidases involved in the inactivation of exogenous and endogenous enkephalins.
Schwartz JC; de la Baume S; Yi CC; Chaillet P; Marcais-Collado H; Costentin J
J Neural Transm Suppl; 1983; 18():235-43. PubMed ID: 6348211
[TBL] [Abstract][Full Text] [Related]
20. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
